[An investigation of extracellular HER-2/NEU domain level in blood serum from breast cancer patients].

Autor: Korytova LI, Masliukova EA, Ovchinnikov IV, Filipenko MO, Korytov OV, Kudaĭbergenova AG
Jazyk: ruština
Zdroj: Voprosy onkologii [Vopr Onkol] 2010; Vol. 56 (1), pp. 62-5.
Abstrakt: A series of 159 tests on HER2 ECD in blood serum from breast cancer patients established the following correlations: enhanced levels of the marker occurred more often in patients with multiple metastases to different organs alongside those with bone metastases; patients in loco-regional relapse tended to show elevated levels too. It is suggested that the method be used for prognosis and monitoring.
Databáze: MEDLINE